ライフサイエンスコーパス: evaluation

1 ET at baseline and after 4 cycles (the first evaluation).

2 mass spectrometer (MS) and interfering with evaluation.

3 r parameters easily obtained during clinical evaluation.

4 hich was corroborated by histolopathological evaluation.

5 sary; and implementation of intervention and evaluation.

6 on; clinical deterioration should prompt its evaluation.

7 y element for parameter estimation and model evaluation.

8 erformance evaluation as opposed to periodic evaluation.

9 likely did not substantially affect our RVE evaluation.

10 d and Fine Needle Aspiration Cytology (FNAC) evaluation.

11 s were referred for comprehensive ophthalmic evaluation.

12 based on the non-destructive fresh materials evaluation.

13 st combinations may add accuracy to clinical evaluation.

14 y that incorporate consistent implementation evaluation.

15 ion sufficient to support implementation and evaluation.

16 ly annotated and used for model training and evaluation.

17 d repair pathway warrant further prospective evaluation.

18 implementation requires careful planning and evaluation.

19 ature changes and total foam volume per time evaluation.

20 tification, disease monitoring, and response evaluation.

21 g sequence for bioluminescence and biosensor evaluation.

22 rectal cancers and warrants further clinical evaluation.

23 ework for qualitative complex system process evaluations.

24 This approach enumerates five domains of evaluation-(1) medical history, (2) physical exam, (3) f

25 ision (55.2%) followed by routine ophthalmic evaluation (13%).

26 slightly less likely than whites to initiate evaluation (49.6% vs 57.9%, P = .11).

27 s for celiac disease must undergo endoscopic evaluation after 1-3 years on a gluten-free diet to eval

28 ve dialysis, mass spectrometry, and in vitro evaluation against the C165S mutant.

29 particles (AuNPs) to provide a comprehensive evaluation, aiming for practical application in biosensi

30 y correlated with TVB-N, TVC, pH and sensory evaluation analysis.

31 nment, Oldenburg-complex molecular mixtures, evaluation & analysis) that integrates published and nov

32 ess to develop Ongoing Professional Practice Evaluation and Focused Professional Practice Evaluation

33 provides clinical considerations for cardiac evaluation and follow-up.

34 r these reasons, clinicians should employ an evaluation and long-term management strategy that accoun

35 %), low-value hospitals had higher inpatient evaluation and management payments ($1405 versus $752, P

36 m the FDA homepage search, ten from the Risk Evaluation and Mitigation Strategy Review, and 256 from

37 r European System for Cardiac Operative Risk Evaluation and more often underwent valve surgery.

38 mily engagement is important, and 7) program evaluation and outcome measurement are a key component o

39 rmis of MFS mice through immunohistochemical evaluation and quantification of elastic and collagen co

40 attrition seen in usual care between initial evaluation and receipt of a PrEP prescription.

41 techniques (CT and MRI) are well suited for evaluation and surgical planning.

42 se of visual impairment, warranting a timely evaluation and synthesis of the scientific literature an

43 Subsequent delays in patient's evaluation and treatment are causing sight loss.

44 apid profiling platform called Morphological Evaluation and Understanding of Stress (MorphEUS).

45 develop a sensitive test of trustworthiness evaluation and use it to document substantial, stable in

46 Evaluation and validation of the outcomes associated wit

47 We analyzed workshop evaluations and audio transcripts of postoperative debri

48 o select promising drug candidates for human evaluation, and to use dynamic clinical trial interventi

49 phone interview shortly after their first KT evaluation appointment.

50 ecommendations, Assessment, Development, and Evaluation) approach was used to evaluate the certainty

51 agents that are entering into early clinical evaluation are discussed.

52 2 mutants provide a strong rationale for its evaluation as a COVID-19 therapeutic.

53 was designed to provide ongoing performance evaluation as opposed to periodic evaluation.

54 Evaluation at 2 years included secondary outcomes of pri

55 ities for refined 3D reconstruction accuracy evaluation, availability of such data is limited due to

56 ry, a novel tool for reference-free assembly evaluation based on efficient k-mer set operations.

57 treatment, but necessitates robust clinical evaluation, biomarker profiling and assessment of comorb

58 here patients underwent nurse-led structured evaluation (blood/urine/eye/feet) in public and private

59 nts are limited as they require an in-person evaluation by a neurology subspecialist or specialized a

60 ere it complements routine histopathological evaluation by clarifying tumor phenotypes.

61 er in IVF cycles relies on the morphological evaluation by embryologists, either by conventional micr

62 In a context-aware blind evaluation by human judges, CUBBITT significantly outper

63 sitive tumor lesions as shown in preclinical evaluation by small-animal PET studies, organ distributi

64 ost predictive of respiratory failure in the evaluation cohort.

65 hould be offered individualized genetic risk evaluation, counseling, and genetic testing.

66 tus), and response to chemotherapy (Response Evaluation Criteria in Solid Tumors) as independent pred

67 r each tumour type according to the Response Evaluation Criteria in Solid Tumours version 1.1 or the

68 ality assessment in terms of all of the four evaluation criteria officially used by CASP, which measu

69 ostate Cancer Molecular Imaging Standardized Evaluation criteria, and the PSMA Reporting and Data Sys

70 ce Evaluation, Focused Professional Practice Evaluation, critical care medicine, healthcare quality,

71 fferent positions in the order of diagnostic evaluations, depending on clinical presentation.

72 The following histo-morphological evaluation dictates therapeutic decisions, where antibio

73 and extend the rate constant evaluation down to 200 K.

74 cardiographic (TTE) and electrocardiographic evaluation during their index hospitalization.

75 Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership,

76 ses related to Ongoing Professional Practice Evaluation, Focused Professional Practice Evaluation, cr

77 ale patients, may be good candidates for OSA evaluation following a CSC diagnosis.

78 Through a deliberate investigation, evaluation for a familial component of cardiomyopathy ca

79 nd hydroxychloroquine, and ivermectin) under evaluation for COVID-19.

80 on for Newly Arriving Refugees, including an evaluation for malnutrition.

81 Skin snip evaluation for onchocerciasis has insufficient sensitivi

82 or inhaled steroids, or unscheduled clinical evaluation for respiratory symptoms.

83 -JADE group (n = 3,587) underwent structured evaluation for risk factors and complications only, whil

84 tory focal epilepsy presumed to be lesional, evaluation for surgery should be considered.

85 d 710 consecutive patients who all underwent evaluation for uveitis including QFT-G testing.

86 The use of the evaluation framework can help to improve decision making

87 Here, we apply a new evaluation framework developed by the Economics of Ecosy

88 Recommendations Assessment, Development, and Evaluation (GRADE) framework.

89 Patients in the early evaluation group had a shorter adjusted time from referr

90 Attempts at accuracy evaluation have relied on simulation and/or FISH imaging

91 nd lower Acute Physiology and Chronic Health Evaluation II scores.

92 ncluding Acute Physiology and Chronic Health Evaluation III scores as a covariate.

93 hort and Acute Physiology and Chronic Health Evaluation III scores, respectively.

94 clude Pathogenesis and Epidemiology, Initial Evaluation, Imaging, Fine Needle Aspiration Biopsy Diagn

95 ould not be overlooked in vaccine design and evaluation.IMPORTANCE Differences in HIV pathogenesis be

96 c PET signal in rat brain to warrant further evaluation in higher species.

97 biological fluids and during pharmacokinetic evaluation in rabbit plasma.

98 Single- and double-pulse TMS evaluation included measurement of the input-output recr

99 tudy is to elucidate the yield of diagnostic evaluation including microbial cultures over a 6.5 year

100 ing framework provides the crucially lacking evaluation indicators for airlines, potentially contribu

101 % CI: 0.40, 0.92) were associated with lower evaluation initiation.

102 Accordingly, the Life After Pediatric Sepsis Evaluation investigation was conducted to describe the t

103 lexes, but their preclinical pharmacological evaluation is limited.

104 Further evaluation is required in the context of a prospective s

105 test unmet needs in the current preoperative evaluation is to assess the presence and severity of sma

106 alogues of disorazole B(1), whose biological evaluation led to the identification of a number of pote

107 Systematic evaluations led to benzophenone-containing probes that e

108 Recommendations Assessment, Development and Evaluation) level of evidence for these conclusions rema

109 es of the jams were determined and a sensory evaluation made.

110 45 (74%) of the evaluations measured significant improvements in health-

111 ecommendations, Assessment, Development, and Evaluation) methodology and the Evidence-to-Decision fra

112 ral distinct considerations to make economic evaluation methods (such as cost-effectiveness analysis)

113 pproach using an assortment of complementary evaluation methods.

114 ndings indicated that rigorous toxicological evaluations must be carried out prior to clinical transl

115 iduals in the Reservoir Assay Validation and Evaluation Network (RAVEN) study cohort (range of 1 to 1

116 we report the radiosynthesis and preclinical evaluation of [(68)Ga]Ga-NOTA-folate ((68)Ga-FOL).

117 ication report, we herein present a thorough evaluation of a green Fmoc removal protocol.

118 in the pathology of index cases.Conclusions: Evaluation of a manufacturing facility with a cluster of

119 n in a variety of ways, including during the evaluation of a possible hematologic malignancy, as an i

120 lemented a new standard mandating a detailed evaluation of a provider's performance.

121 We report the synthesis and evaluation of a series of cell-permeable and N- versus O

122 report the design, synthesis, and biological evaluation of a series of new epothilone B analogues equ

123 these collective data with histopathological evaluation of a swine model of concussion demonstrated a

124 n terms of studying its applicability in the evaluation of abdominal organs and diseases.

125 These data support further evaluation of alcohol withdrawal symptoms as a prognosti

126 Here, through the evaluation of all human TRIM proteins, we find that TRIM

127 acquired without contrast and then a second evaluation of all the sequences, including post-contrast

128 This study aimed to provide a more detailed evaluation of altered structural brain development in ne

129 Herein we present the synthesis and evaluation of anion-binding properties of 12 new recepto

130 procedure applied for the first time to the evaluation of antioxidant activity (AOA) of 6 chlorogeni

131 on and adoption are methodological issues in evaluation of artificial intelligence-based intervention

132 ts of concentration but also on quantitative evaluation of autoantibody aggressiveness.

133 This is especially important in the evaluation of CAD in immune-driven conditions with incre

134 T angiography as the first-line test for the evaluation of CAD, the ISCHEMIA trial also resulted in s

135 Such a nuanced evaluation of cancer and immune metabolism can uncover m

136 ssessment of sarcomere order is paramount in evaluation of cardiac and skeletal myocytes.

137 This study supports further evaluation of cardiac MRI in risk stratification in PAH.

138 (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results [LEADER]; N

139 ODYSSEY OUTCOMES randomized clinical trial (Evaluation of Cardiovascular Outcomes After an Acute Cor

140 ultiparametric monitoring allows the in vivo evaluation of cerebral and cardiovascular haemodynamic r

141 ourth, use of non-randomised studies for the evaluation of clinical benefit in the post-marketing per

142 Evaluation of clinical long-term results 20 years after

143 Evaluation of clinical practices, including medical mana

144 iants along the continuum, allowing improved evaluation of clinical significance, management, and pre

145 Evaluation of CNV Radar in a public multiple myeloma dat

146 creening platform that provided quantitative evaluation of compound activity against two key attribut

147 disease, our platform also incorporated the evaluation of compounds in a panel of primary ADPKD and

148 ex questionnaire (OSDI), tear break-up time, evaluation of corneal and conjunctival staining, Schirme

149 Analysis of FBIC efficacy included evaluation of cytotoxicity, tissue penetration, foam sta

150 This study reports on the cross-sectional evaluation of data of 626 users of mySinusitisCoach (mSC

151 TMPfold was applied for evaluation of DeltaG(asc) in 554 PDB structures of 85 se

152 1C and G2019S knock-in mice enabled thorough evaluation of dendritic spines and synapses on pathway-i

153 ively, this study is the first comprehensive evaluation of deubiquitinases in HIV-1 latency and estab

154 itive assay for INF2 function and for robust evaluation of diseased-linked variants of formin.

155 Based on evaluation of donation impact, consideration should be g

156 M. abscessus pulmonary infection and permits evaluation of efficacies of antibiotics.

157 ration protections to ultrasonic sensing and evaluation of engineering structures.

158 s and are a prerequisite for the statistical evaluation of experimental outcomes.

159 ogic examination is an important part of the evaluation of FASD in childhood as well as in young adul

160 scribe the design, synthesis, and biological evaluation of four linker-drugs, anticipating the constr

161 ated genomic, transcriptional and functional evaluation of gastric premalignancy.

162 The latter term, first coined by the Evaluation of Genomic Applications in Practice and Preve

163 ort the design, synthesis, and antibacterial evaluation of group A streptogramin antibiotics with ext

164 asingly lead the design, implementation, and evaluation of HIV services, which provides an opportunit

165 provide a strong rationale for the advanced evaluation of HSD17B12 inhibition as a promising broad-s

166 wider use of ambulatory BP monitoring in the evaluation of hypertension in patients with CKD.

167 provide insight into the vaccine design and evaluation of immunogenicity to enable rapid translation

168 Herein, we describe the synthesis and evaluation of immunotherapeutic liposomal spherical nucl

169 and tissue proteotypes can improve clinical evaluation of immunotherapies for NSCLC.

170 biomarker of cardiac disease in FRDA and the evaluation of its expression might provide insights into

171 Evaluation of left atrial pressure is frequently require

172 rate (GFR) assessment is a key aspect in the evaluation of living kidney donor candidates; however, d

173 of this work was to conduct the preclinical evaluation of LSPD in terms of pharmacokinetics, ammonia

174 in content representation, as well as in the evaluation of memory traces.

175 In this study, we provide a comprehensive evaluation of methods that detect fully automatically th

176 Herein, the generation and evaluation of multiple machine learning models utilizing

177 s been instrumental in promoting transparent evaluation of new interventions.

178 of key molecular events, which may guide the evaluation of new therapies.

179 ave clear implications for the screening and evaluation of novel adjuvants.

180 More comprehensive and rigorous evaluation of novel electrode materials, application of

181 ss of human IOPD, indicating its utility for evaluation of novel therapeutics.

182 ability studies of ETPs along with cytotoxic evaluation of our designed ETPs against A549, DU 145, He

183 The evaluation of our fragment selection approach was conduc

184 Multidisciplinary evaluation of our national cohort showed no evidence for

185 ert opinion recommendations that help in the evaluation of patients with a history of a pretransplant

186 One of the challenges with urgent evaluation of patients with acute respiratory distress s

187 art disease and discuss implications for the evaluation of patients with stable angina and public pol

188 esis and outline a practical approach to the evaluation of patients with suspected autoinflammation.

189 come an integral component of the diagnostic evaluation of patients with suspected primary immunodefi

190 elusive without a comprehensive, mechanistic evaluation of photocatalysis to better understand how co

191 ay provide a new correlate of protection for evaluation of plague vaccine candidates.

192 One limitation to the evaluation of potential therapies and vaccines to inhibi

193 lutions, application possibilities, critical evaluation of potentialities and limitations as well as

194 ata provide compelling evidence for clinical evaluation of pravastatin as adjunctive, host-directed t

195 lectively, these findings can inform further evaluation of product design and manufacturing processes

196 In addition, the therapeutic evaluation of RA mice by NIR-II PMI is shown to be consi

197 rpretation strategies, including preliminary evaluation of relevant variables, prediction of expected

198 gy testing is not recommended in the routine evaluation of rhinitis.

199 report the design, synthesis, and biological evaluation of several close-in analogs of bryostatin 1.

200 of a commercial breeding program involve the evaluation of several traits simultaneously in a large s

201 mpanion), a software tool that enables rapid evaluation of single-cell proteomic data and recommends

202 The method was also applied for the evaluation of six different post-harvest drying techniqu

203 presented here is not only successful in the evaluation of some important chemical characteristics bu

204 rated by molecular modeling and used for the evaluation of structural differences with a Bgl3 that is

205 Our results suggest that evaluation of such processes might be broadened to inclu

206 allows them to be used directly in unbiased evaluation of synergistic efficacy in drug combinations

207 Docking study and biological evaluation of synthesized compounds has highlighted new

208 etry and chronoamperometry were used for the evaluation of the Au@Pt/Au NPs electrocatalytic activity

209 scribe how these findings have prompted a re-evaluation of the auxiliary role of the bifunctional cla

210 Mendelian randomization (MR) allows the evaluation of the causal role of markers by minimizing t

211 These findings support the clinical evaluation of the combination of LuTate and PARP inhibit

212 Evaluation of the commercial extracts confirmed the vari

213 collection of administered-activity data and evaluation of the diagnostic image quality at baseline;

214 Further evaluation of the EAACI criteria in other European regio

215 Thus, evaluation of the ERCC1-high subgroup was limited.

216 This study reports an evaluation of the impact of extending the shifts of nurs

217 y providing a fully integrated framework and evaluation of the impacts of high VPD on plant function,

218 Herein, we report the evaluation of the metal content in the e-liquids from a

219 The evaluation of the mid-Pliocene adds a constraint to poss

220 Methods: For physiologic evaluation of the mouse hotel, temperature and anesthesi

221 ow report the identification and preclinical evaluation of the novel, clinical ATR inhibitor BAY 1895

222 e epitopes or mAb conjugates, precluding the evaluation of the phosphorylation status of signaling pr

223 Further evaluation of the physiological properties of Lm128C cel

224 y and provide further support for additional evaluation of the potential neuroprotective effects of s

225 n some eye examinations, being necessary the evaluation of the precision of instruments performing su

226 Evaluation of the proposed modulatory effect of irradiat

227 Routine hematological laboratory evaluation of the proposita was normal.

228 Magnetic resonance imaging (MRI) and evaluation of the R2* relaxation rate can be an alternat

229 Pathologic evaluation of the removed endotracheal tube contents fro

230 detect more recent events, in each case with evaluation of the significance of candidate signals by e

231 Evaluation of the target amplicons demonstrated that bot

232 Averaged Navier Stokes, leading to a precise evaluation of the thermal load and drag reductions.

233 We also perform a dosimetric evaluation of the treatment plans based on pCT and rCT i

234 tional epidithiodiketopiperazines (ETPs) and evaluation of their activity against five human cancer c

235 ental testing are implemented to justify the evaluation of their mechanics and reveal the underlying

236 ations are discussed in detail to provide an evaluation of their use in simulations of water in nanop

237 was proposed that allows more comprehensive evaluation of therapies and comparison of outcomes among

238 The authors posit the need for rapid evaluation of therapies for COVID-19 as an inflection po

239 Biological evaluation of these analogues revealed a number of excep

240 pathogenic Ebola viruses and support further evaluation of this approach as a potential addition to E

241 Preclinical data presented here supports the evaluation of TMV-NPNAx5/ALFQ in human trials.

242 Evaluation of tolerability is increasingly relevant for

243 evelopment of the archazolids as well as the evaluation of V-ATPases as a novel and powerful class of

244 19 studies, such as serosurveillance and the evaluation of vaccine candidates.

245 e accounted for when performing retinal OCTA evaluation of VD values.

246 -2 in biological media, while blind clinical evaluations of 100 suspected samples furtherly confirmed

247 According to evaluations of candidate gene prediction performance tes

248 We performed a scoping review of empirical evaluations of dental studies assessing the prevalence a

249 Chronic toxicity evaluations of nanotechnology-based drugs are essential

250 Evaluations of potential new treatments for gonorrhea cu

251 thin SER to provide baseline data for future evaluations of Society initiatives.

252 Evaluations of the grafting approaches were made by comp

253 o quantifying reactivation risks will enable evaluations of the potential impacts of TB control and e

254 Evaluation on 13 well-known repeats show that the inferr

255 it allows for training on small domains and evaluation on arbitrarily-sized inputs, including global

256 assification accuracy when added to clinical evaluation, or reported harms.

257 n psychology are verbal in nature, yet their evaluation overwhelmingly relies on inferential statisti

258 ordings performed as part of the presurgical evaluation, patients with drug-resistant focal epilepsy

259 ular Care is based on the extensive evidence evaluation performed in conjunction with the Internation

260 Study limitations included the short evaluation period (24 months) and the low coverage of UC

261 plex systems influenced intervention design, evaluation planning, or fieldwork.

262 research into the use of CT-FFR for coronary evaluation pre-aortic valve replacement.

263 Evaluation and Focused Professional Practice Evaluation processes in critical care medicine.

264 In vivo evaluation revealed that both surrogates strongly differ

265 covering diverse method comparison and data evaluation scenarios from various subfields of food scie

266 ulate an Acute Physiology and Chronic Health Evaluation score.

267 ts in drylands require careful ecohydrologic evaluation so that green and blue water trade-offs are p

268 fidence interval [CI]: 1.18-1.27), but lower evaluation start among those referred (HR: 0.93; 95% CI:

269 were required to participate in a cross-site evaluation that assessed the impact of BEST activities o

270 ic search to identify complex system process evaluations that involve qualitative methods by searchin

271 a 2-phase framework for qualitative process evaluations that seek to assess changes over time from a

272 ims to analyze published examples of process evaluations that utilize qualitative methods that involv

273 In 14 evaluations, the consideration of complex systems influe

274 Efficacy evaluation through human trials is crucial for advancing

275 roduce a novel method of photodynamic effect evaluation through in situ detection of specific protein

276 Invasive hemodynamic evaluation through right heart catheterization plays an

277 r histo-morphometric and immunohistochemical evaluation to determine the extent of connective tissue

278 eptides, through systematic optimization and evaluation using a glycoprotein interference model, the

279 t rate by recurrent falls (>=2 falls) before evaluation using adjusted regression.

280 VERDICT (Very Early Versus Deferred Invasive Evaluation Using Computerized Tomography in Patients Wit

281 Moreover, a systematic evaluation using nested cross-validation revealed that t

282 At the first evaluation visit (6-8 weeks after treatment), 81% of pat

283 Mean age at cirrhosis evaluation was 62.

284 e different proteins, but the multicomponent evaluation was challenging for proteins at low levels.

285 The Ongoing Professional Practice Evaluation was designed to provide ongoing performance e

286 time of study enrollment when a formal LVAD evaluation was initiated, 162 patient-caregiver dyads co

287 A clinical evaluation was performed in which the ability to detect

288 In 72% of the patients an invasive evaluation was performed, in which electroanatomical vol

289 evere LATE-NC from FTLD-TDP cases with blind evaluation was ~90%.

290 ients undergoing EUS-FNA for pancreatic cyst evaluation, we found the risk of infection to be low.

291 Through systematic evaluation, we have shown that compared to littermate co

292 ailed initial CT features and distributional evaluation were recorded.

293 Sample collections and clinical evaluations were performed before and 3 months after RYG

294 Quantitative and qualitative reader evaluations were performed on the denoised hb DW images.

295 , serology, and clinical data) and molecular evaluation will most likely offer the best diagnostic ap

296 al samples is necessary to obtain a complete evaluation with greater specificity and accuracy.

297 uctions in compressed size, although further evaluation with improved benchmark datasets is required

298 he diagnostic yield of GUM in patients under evaluation with no established diagnosis (n = 139) was 0

299 ngth, chair stands, balance) was measured at evaluation, with frailty defined as liver frailty index

300 fection underwent complete echocardiographic evaluation within 24 hours of admission and were compare